New data for aflibercept show prolonged injection intervals (for specialized target groups only)

Data from ALTAIR study demonstrate injection appointments at an interval of 12 weeks or more / New data submitted to EMA to update the current product information

Source: Bayer Company News - February 12, 2018 Category: Pharmaceuticals Source Type: news